Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared a post on LinkedIn:
“World Pancreatic Cancer Day. Early detection. Real hope.
On this World Pancreatic Cancer Day, our team at Liquid Biopsy LCCRH Lab and Liquid Biopsy Lab CHU de Montpellier (France) is proud to be actively contributing to two major research initiatives focused on the very early detection of pancreatic cancer through liquid biopsy.
PANLIPSY – French National Project
Led at the national level, PANLIPSY aims to advance liquid biopsy technologies and AI to detect pancreatic cancer at its earliest stages, improving diagnostic precision and guiding treatment decisions. Fondation ARC pour la recherche sur le cancer,
Thanks to all our partners and collaborators …
PANCAID – European Collaborative Project
A multidisciplinary European effort accelerating the use of circulating biomarkers to transform early pancreatic cancer detection into clinical practice.
Thanks to all our partners and collaborators …
Through our involvement in both PANLIPSY Project and PANCAID, our laboratory at CHU de Montpellier is deeply committed to bringing innovation from bench to bedside, offering new possibilities for patients and moving closer to a potential cure.
Because when pancreatic cancer is detected early, lives can be saved.”
More posts featuring Catherine Alix-Panabières.